AskBio Receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’s disease investigational gene therapy
Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK MediaRegenerative Medicine ...
Medical Xpress22d
AI model identifies potential risk genes for Parkinson's disease
The npj Parkinson's Disease report uses an approach called "systems biology," which uses AI to integrate and analyze multiple different forms of information from genetic, proteomic, pharmaceutical ...
Pharmabiz17h
AskBio’s gene therapy AB-1005 to treat Parkinson’s disease receives US FDA Regenerative Medicine Advanced Therapy designation
AskBio’s gene therapy AB-1005 to treat Parkinson’s disease receives US FDA Regenerative Medicine Advanced Therapy designation: Berlin, Germany Thursday, February 20, 2025, 10: ...
Parkinson’s Disease: The long-awaited early detection technique is on the horizon
John Sacaria Thirusailam, once very active in life, was forced to leave his well-paid job at the age of 44 after being ...
The Pharma Letter1d
AskBio wins FDA RMAT designation for Parkinson’s gene therapy
Germany-based Bayer’s wholly-owned gene therapy company AskBio today announced that its investigational gene therapy AB-1005 ...
PMLiVE9h
FDA grants RMAT designation to AskBio’s Parkinson’s gene therapy candidate
The US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to AskBio’s investigational Parkinson’s disease (PD) gene therapy. The FDA grants RMAT ...
Gene Therapy: Revolutionizing Medicine By Tackling Diseases At Their Genetic Roots
Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...
Global study identifies markers for the five clinical stages of Parkinson's disease
From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...
Medscape1d
The Genetics of Parkinson Disease: Implications for Neurological Care
During the past decade, Parkinson disease (PD) has evolved from a textbook example of a mostly nonhereditary disease to a complex disorder with a well-established genetic component in a ...
Science Daily23d
Artificial intelligence model identifies potential risk genes for Parkinson's disease
Researchers have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and FDA-approved drugs that ...